Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Wheeler

Showing results (141-150 of 453) with videos related to

Pageof 46
Sort By:
Kidney International Reports|August 15, 2025
Response to the Letter to the Editor Entitled "IMPACT CKD - All Roads Must Not Lead to Dialysis"Juan J Garcia Sanchez, Stacey Priest, Hannah Guiang, et al.
Diabetes, Obesity & Metabolism|May 21, 2025
Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney diseaseVictor Wasehuus, J David Smeijer, Phil Ambery, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2002
Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesionDaniel Zehnder, Rosemary Bland, Ravinder S Chana, et al.
Canadian Journal of Kidney Health and Disease|November 11, 2017
Sex Hormone Status in Women With Chronic Kidney Disease: Survey of Nephrologists' and Renal Allied Health Care Providers' PerceptionsSharanya Ramesh, Matthew T James, Jayna M Holroyd-Leduc, et al.
The Lancet. Diabetes & Endocrinology|April 18, 2019
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trialCarol Pollock, Bergur Stefánsson, Daniel Reyner, et al.
NEJM Evidence|August 26, 2024
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney DiseaseJeffrey T Ha, Swapnil Hiremath, Min Jun, et al.
Kidney International|July 4, 2008
Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Francesco Locatelli, Allen R Nissenson, Brendan J Barrett, et al.
Journal of Cardiac Failure|July 21, 2021
The Potential Roles of Osmotic and Nonosmotic Sodium Handling in Mediating the Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Heart FailurePetter Bjornstad, Peter J Greasley, David C Wheeler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 3, 2020
Area-Level Variation and Human Papillomavirus Vaccination among Adolescents and Young Adults in the United States: A Systematic ReviewElizabeth K Do, Brianna Rossi, Carrie A Miller, et al.
International Journal of Environmental Research and Public Health|July 9, 2022
The Intersection of Neighborhood Environment and Adverse Childhood Experiences: Methods for Creation of a Neighborhood ACEs IndexKrista Schroeder, Levent Dumenci, David B Sarwer, et al.
Pageof 46

Showing results (141-150 of 453) with videos related to

Sort By:
Pageof 46
Kidney International Reports|August 15, 2025
Response to the Letter to the Editor Entitled "IMPACT CKD - All Roads Must Not Lead to Dialysis"Juan J Garcia Sanchez, Stacey Priest, Hannah Guiang, et al.
Diabetes, Obesity & Metabolism|May 21, 2025
Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney diseaseVictor Wasehuus, J David Smeijer, Phil Ambery, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2002
Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesionDaniel Zehnder, Rosemary Bland, Ravinder S Chana, et al.
Canadian Journal of Kidney Health and Disease|November 11, 2017
Sex Hormone Status in Women With Chronic Kidney Disease: Survey of Nephrologists' and Renal Allied Health Care Providers' PerceptionsSharanya Ramesh, Matthew T James, Jayna M Holroyd-Leduc, et al.
The Lancet. Diabetes & Endocrinology|April 18, 2019
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trialCarol Pollock, Bergur Stefánsson, Daniel Reyner, et al.
NEJM Evidence|August 26, 2024
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney DiseaseJeffrey T Ha, Swapnil Hiremath, Min Jun, et al.
Kidney International|July 4, 2008
Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Francesco Locatelli, Allen R Nissenson, Brendan J Barrett, et al.
Journal of Cardiac Failure|July 21, 2021
The Potential Roles of Osmotic and Nonosmotic Sodium Handling in Mediating the Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Heart FailurePetter Bjornstad, Peter J Greasley, David C Wheeler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 3, 2020
Area-Level Variation and Human Papillomavirus Vaccination among Adolescents and Young Adults in the United States: A Systematic ReviewElizabeth K Do, Brianna Rossi, Carrie A Miller, et al.
International Journal of Environmental Research and Public Health|July 9, 2022
The Intersection of Neighborhood Environment and Adverse Childhood Experiences: Methods for Creation of a Neighborhood ACEs IndexKrista Schroeder, Levent Dumenci, David B Sarwer, et al.
Pageof 46